Top Markets
Coin of the day
Dechra Pharmaceuticals PLC Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC

DPH
Rankning i aktier #24497
Dechra Pharmaceuticals PLC is a veterinary-focused enterprise dedicated to the... Dechra Pharmaceuticals PLC is a veterinary-focused enterprise dedicated to the development, production, regulatory approval, marketing, and distribution of animal health products and associated goods for veterinarians. The company's activities are organized across three key segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceutical Research and Development. It supplies a broad range of veterinary treatments, encompassing endocrinology, dermatology, pain management and anesthetics, cardiovascular therapies, and critical care solutions for dogs and cats. For poultry, pigs, and cattle, offerings include water-soluble antibiotics, avian vaccines, and pain relief products. Equine health is addressed with products for lameness and pain. Furthermore, Dechra offers specialized pet nutrition designed to support therapeutic conditions in cats and dogs, such as allergies, obesity, and heart or kidney diseases. Its diversified operations also involve the distribution of veterinary pharmaceuticals and equipment, the provision of financial services, the promotion of pet food, and the creation, regulation, manufacturing, and commercialization of crop protection items. The company’s merchandise is primarily channeled to customers via extensive wholesaler and distributor networks. Founded in 1997 and headquartered in Northwich, UK, Dechra Pharmaceuticals PLC operates globally, with a significant presence in the United Kingdom, Germany, across Europe, the United States, and international markets.
Aktiekurs
$52.60
Senast synkroniserad: 2024-01-15
Marknadsvärde
$59.92M
Förändring (1 dag)
6.81%
Förändring (1 år)
0.00%
Land
GB
Handel Dechra Pharmaceuticals PLC (DPH)

Kategori

EPS för Dechra Pharmaceuticals PLC (DPH)
EPS per 2026 TTM: 0
Enligt Dechra Pharmaceuticals PLCs senaste finansiella rapporter och aktiekurs är bolagets nuvarande EPS (TTM) 0. Vid slutet av 2026 hade bolaget ett EPS på 0, lika med EPS från 2026 som var 0.
EPS-historik för Dechra Pharmaceuticals PLC från 2026 till 2026
EPS vid slutet av varje år
År EPS Ändra
Inte tillräckligt med data för de angivna datumen.
EPS för liknande företag eller konkurrenter
Företag EPS EPS-differens Land
$29.85 -
US
$8.65 -
US
$3.55 -
US
$20.39 -
CH
$1.26 -
US